Otsuka
The pharmas will be employing Verily's Project Baseline platform to streamline recruitment and data collection during clinical research.
Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs.
MobiHealthNews tracked investments, pilots, partnerships and app launches from major pharma companies during the quarter.